What: Shares of Horizon Pharma (NASDAQ: HZNP) dropped by 11.5% in April, according to data from S&P Global Market Intelligence. The drugmaker's monthly decline primarily stemmed from its updated annual guidance that hit the Street last month, and subsequently fell below analysts' expectations in terms of net product sales for the first and second quarter of 2016.
Here's Why Horizon Pharma Plc's Stock Slumped In April
newsfeedback@fool.com (George Budwell), The Motley Fool
Thu, 05/05/2016 - 7:11am
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more